Системные гипертензии

Расширенный поиск

Короткий путь к заветной цели – ко-ренитек для пациента с АГ

Об авторах

И. Е. Чазова
Институт клинической кардиологии им. А.Л.Мясникова Российского кардиологического научно-производственного комплекса МЗ и СР РФ

Л. Г. Ратова
Институт клинической кардиологии им. А.Л.Мясникова Российского кардиологического научно-производственного комплекса МЗ и СР РФ

Список литературы

1. Collins R, Peto R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales J.D, ed. Textbook of Hypertension. Oxford: Blackwell Publications. 1994; 1156–64.

2. Moser M, Herbert P, Hennekens C.R. An overview of the metaanalysis of the hypertension treatment trials. Arch Intern Med 1991; 151: 1277–9.

3. Lewington S et al. Prospective studies collaboration. Age - specific relevance of usual blood pressure to vascular mortality: a meta - analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349): 1903–13.

4. Vasan R.S, Larson M.G et al. Impact of high - normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345 (18): 1291–7.

5. World Health Organization – International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151–83.

6. European Society of Hypertension – European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–53.

7. Chobanian A.V, Bakris G.L, Blorck H.R et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003; 289: 2560–72.

8. Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Российские рекомендации (второй пересмотр). Комитет экспертов Всероссийского научного общества кардиологов. Секция артериальной гипертонии ВНОК. М., 2004. Приложение к журн. "Кардиоваскул. тер. и профилак.".

9. Blood pressure lowering treatment trialists' collaboration. Effects of different blood - pressure - lowering regimens on major cardiovascular events: results of prospectively - designed overviews of randomised trials. Lancet 2003; 362: 1527–35.

10. Brown C.L, Backhouse C.I, Grippat J.C, Santoni J.P. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin - angiotensin system in hypertensive subjects. Eur J Clin Pharmacol 1990; 39: 327–32.

11. Muiesan G, Agabiti-Rosei E, Buoninconti R. Antihypertensive efficacy and tolerability of captopril in elderly: comparison with hydrochlorothiazide and placebo in a multicentre double - blind study. J Hypertens 1987; 2: 89–92.

12. Sassano P, Chatellier G, Billaud E et al. Comparison of increase in the enalapril dose and addition of hydrochlorothizide as second - step treatment of hypertensive patients not controlled by enalapril alone. J Cardiovasc Pharmacol 1989; 13: 314–9.

13. Weinberger M.H. Comparison of captopril and hydrochlorothi - azide alone and in combination in mild to moderate essential hypertension. Br J Clin Pharmacol 1982; 14: 127–31.

14. Zanchetti A, Desche P. Perindopril. First - line treatment for hypertension. Clin Exp Ther Pract 1989; All: 555–73.

15. Scholze J, Group for the East Germany Collaborative Trial. Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. J Hypertens 1993; 11: 217–21.


Для цитирования:

Чазова И.Е., Ратова Л.Г. Короткий путь к заветной цели – ко-ренитек для пациента с АГ. Системные гипертензии. 2005;(2):45-48.

Просмотров: 20

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)